Cite
HARVARD Citation
van der Zee, H. et al. (2020). Weekly adalimumab treatment decreased disease flare in hidradenitis suppurativa over 36 weeks: integrated results from the phase 3 PIONEER trials. Journal of the European Academy of Dermatology and Venereology. pp. 1050-1056. [Online].